POINT Biopharma Global Net Tangible Assets

POINT Biopharma Global (PNT) currently reports a net tangible assets of $420M as of September 2023. That compares with $310M in the prior-year period — up 37.2% year over year. Use the charts on this page to explore POINT Biopharma Global's net tangible assets history and peer comparisons.

POINT Biopharma Global's net tangible assets increased from $310M to $420M — a 37.2% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

POINT Biopharma Global reported $420M in net tangible assets as of September 2023. That compares with $310M in the prior-year period — up 37.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $420M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for POINT Biopharma Global, and consider following PNT for alerts when major investors trade the stock.

POINT Biopharma Global is classified in the Healthcare sector. On net tangible assets, it currently shows $420M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PNT with unrelated industries.